Hi Josh,
I have been a SH since this entity's previous life and therefore significantly higher cost than yours. I have followed it with interest and I hope I will average down sometime in 2019. If you look at the November 2018 Investor Presentation you will appreciate they have stabilised the business after quite an unsettling period while they tried to make the Enzumo business work. Alas, that is almost behind them. Chant West is well respected in the industry they service and you sometimes see one of their team members on financial media being asked for comment re the changes in superannuation and the like.
For me, I think this company will take quite awhile to hit its straps. Therefore I believe we will need to be patient. In the meantime, if I have read the info correctly, the top 6 shareholders appear to be sticking with the company which is good. However with such low daily sales it is a hard coy to get in or out of. Good luck. JMT